MiNDERA is a developer of molecular testing technology designed to be used for skin diseases and conditions. The company specializes in developing and commercializing non-invasive, high precision genomic tools for skin diseases.
Location: Portugal, Porto
Employees: 201-500
Total raised: $13M
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | Grant Park... | grantparkv... |
| - | MIT Alumni... | mitalumnia... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.05.2021 | Series A | $12M | - |
| 13.10.2015 | Seed | $1M | - |
Mentions in press and media 2
| Date | Title | Description |
| 12.05.2021 | Mindera Raises Over $12M in Series A-2 Funding | Mindera Corporation, a San Diego, CA-based company developing and commercializing next-generation medical technology, raised $12.6M in Series A-2 funding. The round was led by Mountain Group Partners, Rockmont Investments, and Scientific He... |
| 13.10.2015 | MiNDERA Closes $1M Seed Financing | MiNDERA Corp., a South San Francisco, CA-based developer of non-invasive molecular diagnostics for dermatology and skin-related cancers, closed a $1m seed financing round. Backers included Scientific Health Development and other individual ... |